NCT06509074View on ClinicalTrials.gov

Beta-Blockers in Takotsubo Syndrome Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Takotsubo CardiomyopathyBeta-blockersEchocardiographyLeft Ventricular Function
Interventions
DRUG

Beta blocker

Pragmatic design. Any beta-blocker with alpha or NO activity may be used

Trial Locations (1)

28006

Hospital Universitario de la Princesa, Madrid

All Listed Sponsors
collaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

lead

Spanish Society of Cardiology

OTHER

NCT06509074 - Beta-Blockers in Takotsubo Syndrome Study | Biotech Hunter | Biotech Hunter